1-(2-Methyloxazol-5-yl)ethanone
| Common Name: |
1-(2-Methyloxazol-5-yl)ethanone |
| IUPAC Name: |
1-(2-methyl-1,3-oxazol-5-yl)ethanone |
| Molecular Formula: |
C6H7NO2 |
| SMILES: |
CC1=NC=C(O1)C(=O)C |
| Inchi: |
1S/C6H7NO2/c1-4(8)6-3-7-5(2)9-6/h3H,1-2H3 |
| Inchi Key: |
ZUAVBZWESOIWQP-UHFFFAOYSA-N |
| Cas No: |
78503-09-0 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
3 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
125.13 |
| Mass (g/mol) |
125.048 |
| Molar Refractivity |
31.66 |
| Net Charge |
|
| HBD |
|
| HBA |
3 |
| Rt Bonds |
1 |
| Rings |
1 |
| TPSA |
43.10 |
| Hetero Atoms |
3 |
| Heavy Atoms |
9 |
| Aromatic Heavy Atoms |
5 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
|
| Vapor Pressure (mmHg@25.00 °C) |
|
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.33 |
| LogP |
1.186 |
| iLOGP |
1.62 |
| XLOGP3 |
0.76 |
| WLOGP |
1.19 |
| MLOGP |
-0.66 |
| ESOL Log S |
-1.44 |
| ESOL Solubility (mg/ml) |
4.55 |
| ESOL Solubility (mol/l) |
0.036 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-1.24 |
| Ali Solubility (mg/ml) |
7.12 |
| Ali Solubility (mol/l) |
0.06 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-1.92 |
| Silicos-IT Solubility (mg/ml) |
1.51 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.52 |
| Bioavailability Score |
0.55 |
| Caco2 |
0 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.579 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.634 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
